BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18541518)

  • 1. [Cost of cancer in France: pharmaceutical expenditure as part of global patients' care].
    Zambrowski JJ
    Bull Cancer; 2008 May; 95(5):535-41. PubMed ID: 18541518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cost of chemotherapy].
    Lévy C; Bonastre J
    Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost of cancer care in Portugal].
    Araújo A; Barata F; Barroso S; Cortes P; Damasceno M; Parreira A; Espírito Santo J; Teixeira E; Pereira R
    Acta Med Port; 2009; 22(5):525-36. PubMed ID: 19944035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost of medications in the oncology sector in the context of health economics].
    Walter E; Batista A
    Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [National Health Insurance expenditures in 1994 for thirty long-term illness].
    Fender P; Païta M; Salanave B; Ganay D; Allemand H
    Sante Publique; 2000 Mar; 12(1):5-19. PubMed ID: 10850139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study based on national DRG data to evaluate work load and practice relating to cancer patients in not-for-profit hospitals].
    Borella L; Peuvrel P; Sauvage M; Maraninchi D; Philip T
    Rev Epidemiol Sante Publique; 2000 Jan; 48(1):53-70. PubMed ID: 10740085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region].
    Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM
    Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for colon cancer--analysis of treatment costs from the perspective of statutory sickness funds.
    Görner M; Riemer-Hommel P
    Z Gastroenterol; 2008 Jul; 46(7):681-8. PubMed ID: 18618379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer treatment at home or in the hospital: what are the costs for French public health insurance? Findings of a comprehensive-cancer centre.
    Raphaël R; Yves D; Giselle C; Magali M; Odile CM
    Health Policy; 2005 May; 72(2):141-8. PubMed ID: 15802149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study based on national DRG data to evaluate work load, practice and cost relating to paediatric oncology in French hospitals].
    Perrier L; Borella L; Marec-Berard P; Crapeau N; Bensadon M; Philip T
    Bull Cancer; 2002 Nov; 89(11):975-83. PubMed ID: 12495886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care costs for treatment of disseminated breast cancer.
    Dahlberg L; Lundkvist J; Lindman H
    Eur J Cancer; 2009 Jul; 45(11):1987-91. PubMed ID: 19398326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering drugs: use and expenditure in Portugal (1995-2004).
    Teixeira IJ; Escoval A; Schiappa M
    Rev Port Cardiol; 2007 May; 26(5):475-93. PubMed ID: 17691275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost aspects of oncologic chemotherapy].
    Knüsli C; Obrecht JP
    Schweiz Rundsch Med Prax; 1989 May; 78(18):515-9. PubMed ID: 2471245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The human and economic burden of cancer in France in 2014, based on the Sniiram national database].
    Tuppin P; Pestel L; Samson S; Cuerq A; Rivière S; Tala S; Denis P; Drouin J; Gissot C; Gastaldi-Ménager C; Fagot-Campagna A
    Bull Cancer; 2017 Jun; 104(6):524-537. PubMed ID: 28285755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The campaign against AIDS and the costs incurred by various forms of management].
    Bez G
    Bull Acad Natl Med; 1990 Nov; 174(8):1175-85. PubMed ID: 2128824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of health expenditures in the first 6 months after the diagnosis of cancer using a population register].
    Belon-Leneutre M; Schraub S; Mercier M; Bourgeois P; Breton C
    Rev Epidemiol Sante Publique; 1988; 36(4-5):318-24. PubMed ID: 3146113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.